Management, Constellation Pharmaceuticals. Victory, Surface Logix raise cash - FierceBiotech. Surface Logix and Ancora Pharmaceuticals Awarded $6.9 Million.
Surface Logix begins trial of SLx-2101 - Pharmaceutical industry news. Anti-Obesity Drug Discovery and Development - Rйsultats Google Recherche de Livres.
He previously served on the boards of Trubion Pharmaceuticals, Surface Logix, Adolor, NetBot, Everyday Learning, Theraclone, Array BioPharma, Caliper Life. 16 Mar 2009 Boston, USA-based Surface Logix has raised over $20.0 million in a combined equity and debt financing. The company received around $15.0.
Surface Logix SLx-4090 Selected Among Top 10 Most Promising
18 Oct 2007 Surface Logix, Inc. announced today that SLx-4090, a clinical-stage in the pharmaceutical, biotechnology, and medical device industries. Dr. Scott Gullicksen has extensive pharmaceutical small molecule discovery and Previous R&D positions include Surface Logix, Sirtris Pharmaceuticals, and.
Surface Logix - ScienceDirect
Surface Logix says heart treatment is well tolerated - Pharmaceutical. Nanotechnology: Importance and Applications - Rйsultats Google Recherche de Livres. 21 Oct 2010 Kates is leading Ischemix. s development of CMX-2043, a drug now in He previously served as senior scientist at Surface Logix Inc. a drug.
Surface Logix, Inc. Brighton in Drug Manufacturers - Major company. A Proven Track Record - Sterling Research Group.
AM-Pharma - David H. Donabedian, PhD.
Robert T. Nelsen, Institute for Systems Biology
23 Apr 2003 Surface Logix is on a fast track to revolutionizing the arts of “From the pharmaceutical standpoint, what is really a black box is [how to look] at. He previously served on the boards of Trubion Pharmaceuticals, Surface Logix,
Aucun commentaire:
Enregistrer un commentaire
Remarque : Seul un membre de ce blog est autorisé à enregistrer un commentaire.